Lifeclean: Steps in the right direction - Redeye

Redeye saw positive sales development and Opex in line with estimates. The gross margin was, however, lower and continues to be volatile. We adjust our estimates downward primarily based on a lower gross margin. The total effect on our Base case value is relatively small even in the light of an increased WACC due to a higher risk-free rate. The new Base case is SEK 9 (10) per share.

Länk till analysen i sin helhet: https://www.redeye.se/research/840905/lifeclean-steps-in-the-right-direction?utm_source=finwire&utm_medium=RSS